Synthesis and analysis of aminochromes by HPLC-photodiode array. Adrenochrome evaluation in rat blood

Biomedical Chromatography

Volumn 17, Issue 1, 2003, Pages 6-13

  Remião, Fernando ^a   Milhazes, Nuno ^a,b   Borges, Fernanda ^a   Carvalho, Félix ^a   Bastos, Maria L ^a   Lemos Amado, Francisco ^c   Domingues, Pedro ^c   Ferrer Correia, A ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^c UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Catecholamines oxidation; Enzymatic oxidation; Non enzymatic oxidation; Tyrosinase

Indexed keywords

AMINES; BLOOD; COPPER COMPOUNDS; IRON COMPOUNDS; MASS SPECTROMETRY; OXIDATION; PHOTODIODES; RATS;

CARDIOTOXICITY; CATECHOLAMINE OXIDATION; ENZYMATIC OXIDATIONS; NEUROTOXICITY; NON-ENZYMATIC; NON-ENZYMATIC OXIDATION; OXIDATION PROCESS; PHOTODIODE ARRAYS; RAT BLOOD; TYROSINASE;

SODIUM COMPOUNDS;

ADRENALIN; ADRENOCHROME; CATECHOLAMINE DERIVATIVE; COPPER SULFATE; DOPA; DOPACHROME; ISOPRENALINE; MONOPHENOL MONOOXYGENASE; NORADRENALIN; OXIDIZING AGENT; POTASSIUM FERRICYANIDE; SILVER DERIVATIVE; SODIUM IODATE;

ACIDIFICATION; ANALYTIC METHOD; ANIMAL EXPERIMENT; CARDIOTOXICITY; CATALYSIS; CONTROLLED STUDY; DEVICE; DIODE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG OXIDATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME MECHANISM; EVALUATION; MALE; NEUROTOXICITY; NONHUMAN; PRECIPITATION; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; TANDEM MASS SPECTROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0037281216     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.203     Document Type: Review

References (30)

1. Beamish RE, Dhillon KS, Singal PK and Dhalla NS. Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. American Heart Journal 1981; 102: 149.
2. Behonick GS, Novak MJ, Nealley EW and Baskin SI. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). Journal of Applied Toxicology 2001; 21: S15.
3. Bindoli A, Rigobello MP and Galzigna L. Toxicity of aminochromes. Toxicology Letters 1989; 48: 3.
4. Bindoli A, Rigobello MP and Deeble DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radical Biology and Medicine 1992; 13: 391.
5. Dhalla KS, Ganguly PK, Rupp H, Beamish RE and Dhalla NS. Measurement of adrenolutin as an oxidation product of catecholamines in plasma. Molecular and Cellular Biochemistry 1989; 87: 85.
6. 2+ transport due to excess catecholamines. Cardiovascular Drugs and Therapy 1996; 10: 231.
7. Dhalla NS, Sasaki H, Mochizuki S, Dhalla KS, Liu X and Elimban V. Catecholamine-induced cardiomyopathy. In Cardiovascular Toxicity, Acosta D (ed.). Raven Press: New York, 2001; 269.
8. Ebina T, Toya Y, Oka N, Schwencke C, Kawabe J-i and Ishikawa Y. Isoform-specific regulation of adenylyl cyclase by oxidized catecholamines. Journal of Molecular and Cellular Cardiology 1997; 29: 1247.
9. Fischer P and Landtsheer L. Métabolisme de l'adrénochrome et du trihydroxyméthylindole chez le lapin. Experimentia 1950; 6: 305.
10. Fliegel L, Takeo S, Beamish RE and Dhalla NS. Adrenochrome uptake and subcellular distribution in the isolated perfused rat heart. Canadian Journal of Cardiology 1985; 1: 122.
11. Foppoli C, Coccia R, Cini C and Rosei MA. Catecholamines oxidation by xanthine oxidase. Biochimica et Biophysica Acta 1997; 1334: 200.
12. Giulivi C and Cadenas E. Oxidation of adrenaline by ferrylmyoglobin. Free Radical Biology and Medicine 1998; 25: 175.
13. Heacock RA. The chemistry of adrenochrome and related compounds. Chemical Review 1959; 59: 181.
14. Keller JN, Huang FF, Dimayuga ER and Maragos WF. Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radical Biology and Medicine 2000; 29: 1037.
15. Lakshmana MK and Raju TR. An isocratic assay for norepinephrine, dopamine and 5-hydroxytrypyamine using their native fluorescent by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat. Analytical Biochemistry 1997; 246: 166.
16. Lemos-Amado F, Domingues P, Ferrer-Correia A, Remião F, Milhazes N, Borges F, Carvalho FD and Bastos ML. Electrospray tandem mass spectrometry of aminochromes. Rapid Communications in Mass Spectrometry 2001; 15: 2466.
17. Martinez-Alvarado P, Dagnino-Subiabre A, Paris I, Metodiewa D, Welch CJ, Olea-Azar C, Ceviedes P, Ceviedes R and Segura-Aguilar J. Possible role of slasolinol quinone methide in the decrease of RCSN-3 cell survival. Biochemical and Biophysical Research Communications 2001; 283: 1069.
18. Matthews SB, Henderson AH and Campbell AK. The adrenochrome pathway: the major route for adrenalin catabolism by polymorpho-nuclear leucocytes. Journal of Molecular and Cellular Cardiology 1985; 17: 339.
19. Miura T, Muraoka S and Fugimoto Y. Inactivation of creatine kinase induced by dopa and dopamine in the presence of ferrylmyoglobin. Chemical-Biological Interactions 1999; 123: 51.
20. Noval JJ, Sohler A, Stackhouse SP and Bryan AC. Metabolism of adrenochrome in experimental animals. Biochemical Pharmacology 1962; 1: 467.
21. Núñez-Delicado E, Pérez-Gilabert M, Sánchez-Ferrer A and García-Carmona F. Hydroperoxidase activity of lipoxygenase: a kinetic study of isoproterenol oxidation. Biochimica et Biophysica Acta 1996; 1293: 17.
22. Ramos K and Acosta D. Cytotoxic actions of isoproterenol in cardiac cells: protective effects of antioxidants. In CRC Handbook of Free Radicals and Antioxidants in Biomedicine, Vol. 2, Miquel J, Quintanilha AT and Weber H (eds). CRC Press: Boca Raton, PL. 1989; 177.
23. Remião F, Carmo H, Carvalho F and Bastos ML. Inhibition of glutathione reductase by isoproterenol oxidation products. Journal of Enzyme Inhibition 1999; 15: 47.
24. Remião F, Carmo H, Carvalho F and Bastos ML. Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. Cardiovascular Toxicology 2001; 1: 195.
25. Riobó NA, Schopfer FJ, Boveris AD, Cadenas E and Poderoso JJ. The reaction of nitric oxide with 6-hydroxydopamine: implications for Parkinson's disease. Free Radical Biology and Medicine 2002; 32: 115.
26. Rona G, Chappel CI, Balazs T and Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Archives of Pathology 1959; 67: 443.
27. Rupp H, Dhalla KS and Dhalla NS. Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. Journal of Cardiovascular Pharmacology 1994; 24 (Suppl. 1): S16.
28. Singal PK, Dhillon KS, Beamish RE, Kapur N and Dhalla NS. Myocardial cell damage and cardiovascular changes due to I.V. infusion of adrenochrome in rats. British Journal of Experimental Pathology 1982; 63: 167.
29. Smythies J and Galzigna L. The oxidative metabolism of catecholamines in the brain: a review. Biochimica et Biophysica Acta 1998; 1380: 159.
30. 2+ transport. Archives of Biochemistry and Biophysics 2001; 387: 85.